MARKET

ALEC

ALEC

Alector
NASDAQ
1.020
-0.030
-2.86%
After Hours: 1.060 +0.04 +3.92% 16:42 05/07 EDT
OPEN
1.050
PREV CLOSE
1.050
HIGH
1.050
LOW
1.000
VOLUME
693.37K
TURNOVER
--
52 WEEK HIGH
6.78
52 WEEK LOW
0.8700
MARKET CAP
101.99M
P/E (TTM)
-0.8276
1D
5D
1M
3M
1Y
5Y
1D
Alector, Inc. (NASDAQ:ALEC) Stock Catapults 27% Though Its Price And Business Still Lag The Industry
Simply Wall St · 2d ago
Weekly Report: what happened at ALEC last week (0428-0502)?
Weekly Report · 2d ago
Weekly Report: what happened at ALEC last week (0421-0425)?
Weekly Report · 04/28 09:17
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 04/25 12:09
Following a 75% decline over last year, recent gains may please Alector, Inc. (NASDAQ:ALEC) institutional owners
Simply Wall St · 04/25 11:34
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 04/24 21:05
Weekly Report: what happened at ALEC last week (0414-0418)?
Weekly Report · 04/21 09:17
Alector completes enrollment in PROGRESS-AD Phase 2 trial of AL01
TipRanks · 04/17 12:06
More
About ALEC
More
Alector, Inc. is a clinical-stage biotechnology company. The Company is focused on developing therapies to counteract the devastating progression of neurodegenerative diseases. It also develops alector brain carrier (ABC), a proprietary blood-brain barrier platform, which is applied to its next-generation product candidates and research pipeline. Its research and drug discovery platform leverages human genetic datasets, advanced tools in bioinformatics and imaging, and insights in neurodegeneration. Its clinical development portfolio includes latozinemab (AL001) and AL101/GSK4527226, while its preclinical and research pipeline candidates include ADP037-ABC, ADP050-ABC, ADP056, and ADP063-ABC/ADP064-ABC. Its first product candidate, latozinemab, is a human recombinant monoclonal antibody that increases the levels of progranulin (PGRN) in the brains of FTD-GRN patients. The AL101/GSK4527226, is a human recombinant monoclonal antibody designed to elevate PGRN levels in the brain.
Recently
Symbol
Price
%Change
    U
  • 20.66
  • -3.10%

Webull offers Alector Inc stock information, including NASDAQ: ALEC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALEC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALEC stock methods without spending real money on the virtual paper trading platform.